All Substitutes
Loading...
Disclaimer
Did you find this information helpful?
Agotrig 0.1mg Injection
Prescription Required
Salt Composition : Triptorelin
Manufacturer : BHARAT SERUMS & VACCINES LTD
Origin of Medicine : India
1 Prefilled Syringe(s)
Introduction to Agotrig 0.1mg Injection
Agotrig 0.1mg injection contains an active component as Triptorelin. It is a medication that belongs to a class of drugs known as gonadotropin-releasing hormone (GnRH) analogs. It is primarily used in the field of reproductive medicine for the treatment of various conditions related to hormonal imbalance. One of the most common uses is in treating certain hormone-dependent conditions such as prostate cancer, breast cancer, and endometriosis. In prostate cancer, for example, this medication is used to lower the levels of testosterone, which can help slow down the growth of cancer cells. It is not recommended to use Agotrig 0.1mg injection in individuals who have a known hypersensitivity or allergic reaction to the medication or any of its components. The safety and effectiveness of this medication have not been established in children, so a healthcare professional will carefully consider and monitor its use in this population.
Adults on Agotrig 0.1mg injection may develop osteoporosis, Therefore, if you or anyone in your immediate family has bone thinning, you should inform your doctor. There may be a risk of development of depression in individuals, hence beware of any mood changes during the course of treatment. It is not recommended to use Agotrig 0.1mg injection in pregnant and nursing individuals. Agotrig 0.1mg injection may have cardiovascular effects, including an increased risk of heart attack or stroke. It should be used cautiously in individuals with a history of cardiovascular disease or those at increased risk. It is necessary to inform your doctor if you have diabetes or heart conditions. It is recommended that you must utilize a method of contraception other than the pill while undergoing therapy. Your physician could advise using a barrier form of birth control, like a condom or diaphragm. It is advised to inform your doctor about all the medicines you are taking including herbal, vitamin supplements and over the counter medicines before starting the treatment.
Uses of Agotrig 0.1mg Injection
- Prostate cancer in men
- Early onset puberty in children 2 years of age and older (precocious puberty)
- Used to treat Endometriosis in females - a condition in which the tissue that normally lines the uterus—grows outside of it.
Therapeutic Effects of Agotrig 0.1mg Injection
Agotrig 0.1mg injection exerts its therapeutic effect by suppressing the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) through its action on the pituitary gland. This suppression leads to a decrease in the production of sex hormones, such as testosterone and estrogen. By reducing the levels of these hormones, this medication is beneficial in treating hormone-dependent conditions such as prostate cancer, breast cancer, and endometriosis.
Interaction of Agotrig 0.1mg Injection with other drugs
Inform the doctor about your medicines, including prescription, over-the-counter, nutritional or vitamin supplements, and herbal products. Certain medications may interact with Agotrig 0.1mg injection , reducing effectiveness by causing undesirable side effects.
More Information about Agotrig 0.1mg Injection
- Store at room temperature, between 20°C to 25°C (68°F to 77°F).
- Keep away from moisture, heat, and light.
- It should not be frozen.
- Keep away from children and pets.
How to consume Agotrig 0.1mg Injection
Agotrig 0.1mg injection is typically administered via injection, either subcutaneously (under the skin) or intramuscularly (into the muscle). The specific dosing and frequency of administration will depend on the individual's condition being treated and their response to the medication. It is important to follow the healthcare professional's instructions regarding the administration technique and schedule.
Safety Advices for Agotrig 0.1mg Injection
Pregnancy
Agotrig 0.1mg injection is generally not recommended for use during pregnancy. If pregnancy is planned or suspected while using this medication, it is important to inform the healthcare professional promptly. They can provide appropriate guidance and make necessary adjustments to the treatment plan.
Breast Feeding
The safety of Agotrig 0.1mg injection during breastfeeding is not well established. It is advisable to avoid using it while breastfeeding unless the potential benefits outweigh the potential risks to the nursing infant.
Lungs
Agotrig 0.1mg injection is generally considered safe for use in individuals with lung conditions. However, as with any medication, it is important to consult with a healthcare professional before starting this medication if you have a lung condition or any respiratory issues.
Liver
Agotrig 0.1mg injection should be used with caution in individuals with liver impairment or liver disease. The metabolism and elimination of this medication may be affected in such cases. It is advised to consult a healthcare provider if you have any concerns on liver health.
Alcohol
It is usually not advised to drink alcohol while receiving Agotrig 0.1mg injection therapy. The body's hormone levels, particularly those related to reproductive function, might be impacted by alcohol consumption.
Driving
Common side effects of Agotrig 0.1mg injection may include hot flashes, mood changes, and fatigue. If any of these side effects occur and significantly impact your alertness, concentration, or motor skills, it is advisable to avoid driving or operating machinery until you feel capable of doing so safely.
Side Effects of Agotrig 0.1mg Injection
Agotrig 0.1mg injection causes some side effects like all medications, although not everyone will experience them.
Serious:
- Severe allergic reaction (angioedema, anaphylactic reaction)
- Swallowing or breathing trouble
- Increased lymphocytes count in the blood
- Swelling of lips, tongue or throat
Common:
- Hot flushes
- Weakness
- Excessive sweating
- Back pain
- Impotence
- Nausea
- Dry mouth
- Pain, bruising, redness at the injection site
- High blood pressure
- Weight gain
- Dizziness
- Headache
- Decreased libido
- Painful periods
Word of Advice
It is important to use Agotrig 0.1mg injection with caution and adhere to the following precautions to ensure its safe and effective use. First, always use under the supervision and guidance of a healthcare professional who can monitor your progress and make necessary adjustments to your treatment plan. Inform your healthcare professional about any existing medical conditions, including liver impairment, lung conditions, or pregnancy or breastfeeding, as it may have specific considerations or contraindications in these cases. Adhere to the prescribed dosage and administration instructions, and do not adjust the dose without consulting your healthcare professional.
Be aware of possible side effects, such as hot flashes, mood changes, or fatigue, and promptly report any concerning or persistent symptoms to your healthcare professional. Regular follow-up appointments and monitoring are essential to assess your response to this medication and address any concerns or issues that may arise. By taking these precautions and maintaining open communication with your healthcare professional, you can maximize the benefits of this medication while minimizing potential risks.
FAQs
Q 1. Can Agotrig 0.1mg injection be used to treat infertility?
Yes, Agotrig 0.1mg injection can be used in certain cases to treat infertility. It is sometimes prescribed as part of assisted reproductive technologies, such as in vitro fertilization (IVF) or intrauterine insemination (IUI), to regulate the timing of ovulation and enhance the chances of successful fertilization.
Q 2. What is the usual duration of Agotrig 0.1mg injection treatment?
The duration of Agotrig 0.1mg injection treatment can vary depending on the specific condition being treated. In some cases, it may be a short-term treatment lasting a few weeks or months, while in other cases, such as in prostate cancer, it may be a long-term treatment lasting several months or years. The duration of treatment is determined by the healthcare professional based on individual factors and treatment goals.
Q 3. Can Agotrig 0.1mg injection cause menopause-like symptoms?
Yes, Agotrig 0.1mg injection can cause menopause-like symptoms such as hot flashes, night sweats, and mood changes. These symptoms occur due to the suppression of sex hormone levels, particularly estrogen, which happens due to Agotrig 0.1mg injection 's mechanism of action. These side effects are usually temporary and may resolve after discontinuing the medication.
Q 4. Are there any drug interactions associated with Agotrig 0.1mg injection?
Agotrig 0.1mg injection may interact with certain medications, including hormonal therapies and drugs that affect the function of the pituitary gland. It is important to inform your healthcare professional about all the medications you are taking, including prescription, over-the-counter, and herbal products, to minimize the risk of potential interactions.
Q 5. Can Agotrig 0.1mg injection be used in children?
The safety and effectiveness of Agotrig 0.1mg injection have not been well established in children. Its use in pediatric patients is generally limited and carefully considered on a case-by-case basis. Pediatric patients would require close monitoring and supervision by a healthcare professional familiar with the use in this population.
Fact Box of Agotrig 0.1mg Injection
Molecule name: Triptorelin | Therapeutic class: Hormonal therapy |
Pharmacological class: Gonadotropin-releasing hormone (GnRH) analog
| Indications: 1. Prostate cancer 2. Precocious puberty |
Dosage form: Injection | Habit forming: No |
References
- Ipsen Limited, Electronic Medicines Compendium (EMC), [Revised on June 2023] [Accessed on 13th March 2024], https://www.medicines.org.uk/emc/files/pil.780.pdf
- Allergan, US Food & Drug Administration, [Revised on Dec 2018] [Accessed on 13th March 2024], https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020715s040,021288s035,022427s015lbl.pdf
- Claudine Isaacs, Anton Wellstein, and Anna T. Riegel, Hormones and Related Agents in the Therapy of Cancer, Goodman & Gilman’s Pharmacological Basis of Therapeutics, 13th Edition, 2018, 1237-1247.
Disclaimer
MrMed’s primary intention is to ensure that its consumers get information that experts, accurate and trustworthy, review. The information and contents of this website are for informational purposes only. They are not intended to substitute for professional medical advice, diagnosis, or treatment. Please seek your doctor's advice and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.
